NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai Gozani, M.D., Ph.D., and NeuroMetrix’spresident and chief executive officer, the Waltham, Massachusetts-based company was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. For more information, visit the company’s website atwww.neurometrix.com.